These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment. Webster RG; Cossins J; Lashley D; Maxwell S; Liu WW; Wickens JR; Martinez-Martinez P; de Baets M; Beeson D Exp Neurol; 2013 Oct; 248():286-98. PubMed ID: 23797154 [TBL] [Abstract][Full Text] [Related]
4. The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes. Rodríguez Cruz PM; Palace J; Beeson D Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874875 [TBL] [Abstract][Full Text] [Related]
5. [Molecular bases and therapeutic strategies in defective neuromuscular transmissions: lessons learned from a prototypical synapse]. Ohno K; Ito M; Masuda A Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Aug; 29(4):145-51. PubMed ID: 19764481 [TBL] [Abstract][Full Text] [Related]
6. Congenital myasthenic syndromes in 2012. Engel AG Curr Neurol Neurosci Rep; 2012 Feb; 12(1):92-101. PubMed ID: 21997714 [TBL] [Abstract][Full Text] [Related]
7. Electrophysiological and morphological characterization of a case of autosomal recessive congenital myasthenic syndrome with acetylcholine receptor deficiency due to a N88K rapsyn homozygous mutation. Yasaki E; Prioleau C; Barbier J; Richard P; Andreux F; Leroy JP; Dartevelle P; Koenig J; Molgó J; Fardeau M; Eymard B; Hantaï D Neuromuscul Disord; 2004 Jan; 14(1):24-32. PubMed ID: 14659409 [TBL] [Abstract][Full Text] [Related]
8. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Engel AG; Shen XM; Selcen D; Sine SM Lancet Neurol; 2015 Apr; 14(4):420-34. PubMed ID: 25792100 [TBL] [Abstract][Full Text] [Related]
9. Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates. Belaya K; Finlayson S; Slater CR; Cossins J; Liu WW; Maxwell S; McGowan SJ; Maslau S; Twigg SR; Walls TJ; Pascual Pascual SI; Palace J; Beeson D Am J Hum Genet; 2012 Jul; 91(1):193-201. PubMed ID: 22742743 [TBL] [Abstract][Full Text] [Related]
14. Congenital myasthenic syndromes and the formation of the neuromuscular junction. Beeson D; Webster R; Cossins J; Lashley D; Spearman H; Maxwell S; Slater CR; Newsom-Davis J; Palace J; Vincent A Ann N Y Acad Sci; 2008; 1132():99-103. PubMed ID: 18567858 [TBL] [Abstract][Full Text] [Related]
15. Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain. Logan CV; Cossins J; Rodríguez Cruz PM; Parry DA; Maxwell S; Martínez-Martínez P; Riepsaame J; Abdelhamed ZA; Lake AV; Moran M; Robb S; Chow G; Sewry C; Hopkins PM; Sheridan E; Jayawant S; Palace J; Johnson CA; Beeson D Am J Hum Genet; 2015 Dec; 97(6):878-85. PubMed ID: 26626625 [TBL] [Abstract][Full Text] [Related]
16. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations. Rodríguez Cruz PM; Cossins J; Estephan EP; Munell F; Selby K; Hirano M; Maroofin R; Mehrjardi MYV; Chow G; Carr A; Manzur A; Robb S; Munot P; Wei Liu W; Banka S; Fraser H; De Goede C; Zanoteli E; Conti Reed U; Sage A; Gratacos M; Macaya A; Dusl M; Senderek J; Töpf A; Hofer M; Knight R; Ramdas S; Jayawant S; Lochmüller H; Palace J; Beeson D Brain; 2019 Jun; 142(6):1547-1560. PubMed ID: 31081514 [TBL] [Abstract][Full Text] [Related]